Join WhatsApp Group Join Now
Join Telegram Group Join Now

Glenmark's COVID-19 treatment medicine

Bhavesh Chothani
Glenmark's COVID-19 treatment medicine:: Amidst the fight against corona virus, drug company Glenmark Pharmaceuticals' drug Fabiflu can now be used in the treatment of corona virus patients. Glenmark Pharmaceuticals has also received permission from the government. Patients with common symptoms of corona will be given medication from Glenmark Pharmaceuticals.

Glenmark's COVID-19 treatment medicine


Glenmark Pharmaceuticals said the company has introduced the antiviral drug Favipiravir from the Fabiflu brand to treat patients with corona virus. Glenmark Pharmaceuticals has been approved by CDSCO on June 15 for the manufacture and marketing of Favipiravir i.e. Fabiflu.

The company has received approval for the drug at a time when coronavirus infections are gaining momentum in India. Cases of corona virus are growing faster in India than ever before. The number of coronavirus patients in India has crossed four lakh. The company said that the drug will be available at Rs 104 but a prescription will be required to take the drug.

Glenmark's COVID-19 treatment medicine



Ahmedabad: Drug company Glenmark Pharma has developed an antiviral drug to treat corona virus. Glenmark's drug Favipiravir has been introduced under the Fabiflu brand. The country's leading pharmaceutical company gave this information today. The company said yesterday that it has received approval from DGCI to manufacture and market the drug Fabiflu.

  Favipiravir is a drug for the treatment of Fabiflu covid 19, Glenmark Pharma said. Although this drug is not for everyone, it can be effective for patients with mild coronary heart disease. Glenn Saldah, chairman and managing director of Glenmark Pharma, said the number of coronavirus cases in India has increased so much that the drug has been approved at a time when our healthcare system is operating under a lot of pressure.

  He further hoped that an effective drug like Fabiflu would go a long way in reducing the increased pressure on the corona. Saldanha said that in clinical trials, Fabiflu has shown very good results in patients suffering from mild coronavirus infection. The drug will be available at Rs 103 per tablet on a doctor's prescription. This is India's first drug to treat corona. The drug can be given to patients with heart disease and diabetes as well as reduces the viral load in the body within four days. On the first day two doses of Fabiflu 1800 MG should be taken while for 14 days two doses of 800 MG should be taken.

FabiFlu: All you need to know about Glenmark's COVID-19 treatment medicine

:-:-:IMPORTANT LINK:-:-:
Read news Navgujarat samy
Read Akila NEWS